Cargando…

Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data

BACKGROUND: Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disorder with limited robust disease-modifying therapies presently available. While several treatments are aimed at improving health-related quality of life (HRQoL), longitudinal data on how QoL changes across...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prell, Tino, Gaur, Nayana, Steinbach, Robert, Witte, Otto W., Grosskreutz, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195704/ https://www.ncbi.nlm.nih.gov/pubmed/32357946 http://dx.doi.org/10.1186/s12955-020-01372-6

Ejemplares similares

Monocyte-Derived Macrophages Contribute to Chitinase Dysregulation in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Gaur, Nayana, et al.
Publicado: (2021)

Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model
por: Steinbach, Robert, et al.
Publicado: (2020)

Poor emotional well-being is associated with rapid progression in amyotrophic lateral sclerosis
por: Prell, Tino, et al.
Publicado: (2019)

Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model
por: Steinbach, Robert, et al.
Publicado: (2020)

Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2021)

Blood–Brain Barrier Disruption Is Not Associated With Disease Aggressiveness in Amyotrophic Lateral Sclerosis
por: Prell, Tino, et al.
Publicado: (2021)

Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2019)

Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging
por: Prell, Tino, et al.
Publicado: (2019)

The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond
por: Gaur, Nayana, et al.
Publicado: (2020)

Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a “Global Cohort”
por: Steinbach, Robert, et al.
Publicado: (2018)

Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis
por: Keil, Carsten, et al.
Publicado: (2012)

Use of vitamins by participants in amyotrophic lateral sclerosis clinical trials
por: Prell, Tino, et al.
Publicado: (2020)

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
por: Dreger, Marie, et al.
Publicado: (2021)

Susceptibility-Weighted Imaging Provides Insight into White Matter Damage in Amyotrophic Lateral Sclerosis
por: Prell, Tino, et al.
Publicado: (2015)

Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness
por: Dieckmann, Nora, et al.
Publicado: (2022)

The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis
por: Tadic, Vedrana, et al.
Publicado: (2014)

Voxel-Based MRI Intensitometry Reveals Extent of Cerebral White Matter Pathology in Amyotrophic Lateral Sclerosis
por: Hartung, Viktor, et al.
Publicado: (2014)

Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?
por: Prell, Tino, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

Classification of amyotrophic lateral sclerosis by brain volume, connectivity, and network dynamics
por: Thome, Janine, et al.
Publicado: (2021)

Amyotrophic Lateral Sclerosis: Advances and Prospects
por: Boentert, Matthias, et al.
Publicado: (2023)

Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2016)

Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease
por: Perner, Caroline, et al.
Publicado: (2019)

Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
por: Prell, Tino, et al.
Publicado: (2019)

Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease
por: Prell, Tino, et al.
Publicado: (2019)

DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1(G93A) model of amyotrophic lateral sclerosis in vivo and in vitro
por: Penndorf, Diane, et al.
Publicado: (2017)

Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson’s disease: A cross-sectional study
por: Gruber, Maria Theresa, et al.
Publicado: (2020)

DNA plasticity and damage in amyotrophic lateral sclerosis
por: Penndorf, Diane, et al.
Publicado: (2018)

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
por: Grosskreutz, Julian, et al.
Publicado: (2006)

Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
por: Prell, Tino, et al.
Publicado: (2020)

Longitudinal biomarkers in amyotrophic lateral sclerosis
por: Huang, Fen, et al.
Publicado: (2020)

Data on adherence to medication in neurological patients using the German Stendal Adherence to Medication Score (SAMS)
por: Prell, Tino, et al.
Publicado: (2019)

Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness
por: Thorns, Johannes, et al.
Publicado: (2013)

Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis
por: Barć, Krzysztof, et al.
Publicado: (2020)

Impact of subthreshold depression on health-related quality of life in patients with Parkinson’s disease based on cognitive status
por: Schönenberg, Aline, et al.
Publicado: (2021)

Clinical Course of Atopic Dermatitis in an Adult with Amyotrophic Lateral Sclerosis: Aetiological Implications of Voluntary Movements and Dermatitis Severity
por: KIYOHARA, Tatsushi, et al.
Publicado: (2022)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

What Predicts Different Kinds of Nonadherent Behavior in Elderly People With Parkinson's Disease?
por: Mendorf, Sarah, et al.
Publicado: (2020)

Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life
por: Grande, Giulia, et al.
Publicado: (2017)

Serum programmed cell death proteins in amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dn3757395tnvl468qbn1129v5n